Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Modern Dairies Ltd

MODAIRY
BSE
39.68
3.04%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Modern Dairies Ltd

MODAIRY
BSE
39.68
3.04%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
113Cr
Close
Close Price
39.68
Industry
Industry
Food & Dairy Products
PE
Price To Earnings
4.28
PS
Price To Sales
0.33
Revenue
Revenue
339Cr
Rev Gr TTM
Revenue Growth TTM
-4.53%
PAT Gr TTM
PAT Growth TTM
-68.62%
Peer Comparison
How does MODAIRY stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
MODAIRY
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
8183811009894748991788287
Growth YoY
Revenue Growth YoY%
61.489.890.6102.720.913.6-8.4-11.2-6.9-17.111.0-1.4
Expenses
ExpensesCr
767977949089708689757985
Operating Profit
Operating ProfitCr
544675432332
OPM
OPM%
5.74.84.96.27.65.35.53.51.93.93.32.7
Other Income
Other IncomeCr
00190000560000
Interest Expense
Interest ExpenseCr
111111000000
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
32215643581222
Tax
TaxCr
00000000-17000
PAT
PATCr
322156435818221
Growth YoY
PAT Growth YoY%
4.4-23.8403.370.6142.091.1-84.41,181.6181.7-57.3-49.1-97.9
NPM
NPM%
3.22.426.54.56.54.14.565.319.62.12.11.4
EPS
EPS
1.10.99.21.92.71.61.424.87.50.60.60.5

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
625497457467560766610241217362348339
Growth
Revenue Growth%
-2.0-20.5-8.02.120.136.6-20.3-60.6-9.666.2-3.7-2.7
Expenses
ExpensesCr
629499463480549757600231201340334329
Operating Profit
Operating ProfitCr
-3-2-6-14119101017221410
OPM
OPM%
-0.6-0.4-1.3-2.92.01.11.74.17.76.04.02.9
Other Income
Other IncomeCr
1014000-222120571
Interest Expense
Interest ExpenseCr
171817000002421
Depreciation
DepreciationCr
5555562263333
PBT
PBTCr
-24-24-13-1963-3551234666
Tax
TaxCr
-2000000000-17-16
PAT
PATCr
-22-24-13-1963-35512348322
Growth
PAT Growth%
-335.6-8.944.9-39.0132.6-42.4-1,095.9114.3145.5181.6142.4-73.0
NPM
NPM%
-3.6-4.9-2.9-4.01.10.5-5.72.15.69.523.86.6
EPS
EPS
-9.5-10.4-4.9-8.02.61.5-14.92.15.214.735.59.3

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
232323232323232323232626
Reserves
ReservesCr
-57-81-95-111-105-102-136-131-119-85718
Current Liabilities
Current LiabilitiesCr
1351471142032162081861691801426868
Non Current Liabilities
Non Current LiabilitiesCr
9885109211111999
Total Liabilities
Total LiabilitiesCr
19917415111713613074628590117120
Current Assets
Current AssetsCr
1169374315153382851546364
Non Current Assets
Non Current AssetsCr
838177868478363334365456
Total Assets
Total AssetsCr
19917415111713613074628590117120

Cash Flow

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
1730-101646717154720
Investing Cash Flow
Investing Cash FlowCr
-2-20-3-4-5-3-2-3-5-4
Financing Cash Flow
Financing Cash FlowCr
-16-226-110-2-3-9-19-41-10
Net Cash Flow
Net Cash FlowCr
-16-51-1-106-717
Free Cash Flow
Free Cash FlowCr
1528-1113-11315124317
CFO To PAT
CFO To PAT%
-76.3-124.478.2-85.759.5179.4-19.3338.9124.4138.624.3
CFO To EBITDA
CFO To EBITDA%
-489.6-1,515.0176.4-117.032.072.065.8170.890.4219.3144.3

Ratios

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2723291612523184469136
Price To Earnings
Price To Earnings
0.00.00.00.02.01.30.03.63.62.01.6
Price To Sales
Price To Sales
0.00.10.10.00.00.00.00.10.20.20.4
Price To Book
Price To Book
-0.8-0.4-0.4-0.2-0.1-0.1-0.2-0.2-0.5-1.14.2
EV To EBITDA
EV To EBITDA
-55.4-86.2-34.5-1.10.90.52.21.12.63.59.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
7.07.36.65.39.66.78.723.330.422.520.6
OPM
OPM%
-0.6-0.4-1.3-2.92.01.11.74.17.76.04.0
NPM
NPM%
-3.6-4.9-2.9-4.01.10.5-5.72.15.69.523.8
ROCE
ROCE%
-5.1-6.93.121.0-7.7-4.630.7-4.7-15.4-70.7170.0
ROE
ROE%
66.141.818.821.1-7.4-4.530.7-4.6-12.7-55.5255.4
ROA
ROA%
-11.2-13.9-8.8-15.94.52.7-46.68.014.338.171.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Modern Dairies Limited (**MDL**) is a prominent Indian dairy processor headquartered in **Chandigarh** with a centralized, integrated manufacturing facility in **Karnal, Haryana**. Operating as a single primary reportable segment under **Ind AS 108**, the company specializes in the procurement and processing of raw milk into a diverse range of fresh dairy products, cultured health foods, and specialized nutritional ingredients. The company serves a dual market: providing high-quality consumer goods to the domestic market and acting as a strategic B2B supplier of specialized ingredients to leading multinational food and pharmaceutical companies operating in India. --- ### Specialized Product Portfolio & Market Positioning MDL has transitioned from a traditional milk processor to a value-added dairy player, focusing on **protein-rich** and **fortified** options to meet evolving consumer health trends. * **Fresh & Value-Added Dairy:** Liquid Milk (including fortified variants), Pure Ghee, Butter, Paneer, and traditional Indian dairy products like Dahi, Lassi, and Chachh. * **Milk Powders:** Skimmed Milk Powder (**SMP**), Whole Milk Powder (**WMP**), and Dairy Whitener. * **Nutritional & Pharma Ingredients:** * **Casein** and **Whey Protein Concentrate (WPC)** for the health and fitness industry. * **Pharma Grade Lactose**, catering to the stringent requirements of the pharmaceutical sector. * **Health & Probiotics:** Flavored Yoghurts and Probiotic drinks designed for health-conscious consumers. --- ### Manufacturing Excellence & Quality Benchmarks The company’s operations are concentrated at its facility at **136 KM, G.T. Road, Karnal**, which is strategically located in a high-milk-yield belt. As of March 31, 2025, the facility is supported by a workforce of **453 persons**. MDL maintains a rigorous quality framework to sustain its status as an approved supplier to global multinationals: | Certification / Approval | Issuing Authority / Standard | |:---|:---| | **Quality Management** | **ISO 9001**, **FSSC 22000** (Certified by DNVGL Netherlands) | | **Environmental Management** | **ISO 14001** | | **Pharma Grade Lactose** | **WHO-GMP** (Good Manufacturing Practices) | | **Export Compliance** | **USFDA**, **Export Inspection Agency**, **APEDA**, **HALAL** | **Operational Efficiency Metrics:** The company monitors utility consumption per **1,000 kgs** of milk processed to drive cost-efficiency: * **Electricity Consumption:** Ranges between **80.25 - 86.27 kwh**. * **Fuel Quantity:** Ranges between **67.35 - 82.21 kgs**. --- ### Capital Restructuring & Promoter Equity Infusion To strengthen its balance sheet and fund long-term working capital, MDL is executing a significant capital raising plan through the issuance of convertible securities to its promoter group. * **Preferential Allotment:** The company is raising **Rs. 43 Crore** via **86,00,000 Convertible Warrants** at an issue price of **Rs. 50** (including a **Rs. 40 premium**). * **Warrant Conversion Progress:** As of February 2026, **39,00,000 warrants** have been converted into equity, realizing **Rs. 14.625 Crore** in capital. * **Authorized Capital:** In September 2024, the company increased its authorized share capital from **Rs. 30 Crore** to **Rs. 35 Crore** to facilitate this expansion. * **Promoter Commitment:** Despite the infusion, **45.69%** of the total share capital (**1,06,54,779 shares**) remains pledged to lenders as part of historical debt arrangements. --- ### Financial Performance & Debt Resolution While MDL has shown strong revenue growth over a three-year horizon, recent performance has been tempered by raw material price volatility. **Financial Summary (₹ in Lacs):** | Metric | FY 2024-25 | FY 2023-24 | FY 2022-23 | | :--- | :--- | :--- | :--- | | **Total Revenue** | **3,48,92** | **3,62,04** | **2,18,76** | | **Operating Profit** | **14,77** | **22,19** | **18,00** | | **Dividend** | **Nil** | **Nil** | **Nil** | **Debt Resolution Milestones:** The company has successfully navigated a period of financial stress through **One-Time Settlements (OTS)**: * **Punjab National Bank (PNB):** Settled for **Rs. 45.94 Crore** in November 2024; all dues are now fully cleared. * **Canara Bank:** Settled for **Rs. 9.95 Crore** in January 2025. * **Edelweiss ARC:** Debt restructured and fully paid off by August 2023, resulting in an exceptional gain of **Rs. 27.95 Crore** from debt write-offs. --- ### Strategic Partnerships & Governance MDL leverages related party synergies to optimize its supply chain and market reach: * **Modern Dairyfarms Limited:** A strategic sourcing arrangement with a shareholder-approved transaction limit of **Rs. 180 Crore** per annum. * **Nabha Commerce Private Limited:** A material agreement for product sales/purchases capped at **Rs. 60 Crore** per year through **2030**. * **Board Continuity:** **Dr. Meena Sharma** was re-appointed as an Independent Director until **2027**, ensuring stability following the demise of a board member in early 2025. --- ### Critical Risk Factors & Contingencies Investors should note several significant legal and regulatory headwinds: **1. Milk Cess Litigation (High Exposure):** The company is contesting a levy under the **Haryana Murrah Buffalo and other Animal Breed Act, 2001**. * The Government of Haryana has demanded **Rs. 544.31 Crore** (including interest). * The matter is currently pending as a **Special Leave Petition (SLP)** in the **Supreme Court**. * MDL has provided **Rs. 21.74 Crore** in its accounts as a cautionary measure and deposited **Rs. 9.91 Crore** with authorities. **2. Managerial Remuneration Audit Qualification:** Auditors have flagged **Rs. 3.57 Crore** in remuneration paid to the Managing and Executive Directors that does not comply with **Section 197 of the Companies Act, 2013**. This remains a "Qualified Opinion" in audit reports pending formal approval or refund. **3. Margin & Macro Risks:** * **Raw Milk Volatility:** High procurement prices in **FY25** directly compressed margins. * **Taxation:** The company has **not recognized deferred tax assets** due to the lack of "virtual certainty" regarding future taxable profits amidst ongoing litigation. * **Labour Codes:** The impact of the new **2019-2020 Labour Codes** is yet to be fully determined as final rules are awaited. --- ### Future Outlook The company’s strategy for the upcoming fiscal year rests on **product mix optimization** and **operational deleveraging**. With the completion of major bank settlements and a focus on high-margin **nutritional ingredients**, MDL aims to capitalize on a favorable monsoon forecast and stabilized milk availability to restore profitability margins.